Leiden, Netherlands

Prosensa Technologies B.v.

Calculating rank
USPTO Granted Patents = 4

% Expired Patents = 75.0


Forward Citations = 95

Loading Chart...
Loading Chart...

9 inventors (with patents filed for the assignee):

goldMedal Gerard Johannes Platenburg (3 out of 16 patents)

silverMedal Judith Christina Theodora Van Deutekom (3 out of 23 patents)

bronzeMedal Josephus Johannes De Kimpe (2 out of 15 patents)

4.  Annemieke Aartsma-Rus (2 out of 12 patents)

5.  Garrit-Jan Boudewijn Van Ommen (2 out of 19 patents)

6.  Petra Van Kuik-Romeijn (2 out of 4 patents)

7.  Joseph Stephan Verbeek (1 out of 1 patent)

8.  Aliye Seda Ylmaz-Elis (1 out of 1 patent)

9.  Johannes Antonius Heemskerk (1 out of 2 patents)

10.  Derick Gert Wansink (3 patents)

11.  Gerardus Johannes Platenburg (8 patents)


4 patents:

Company Overview
Prosensa Technologies B.V. is a leading biotechnology company focusing on the development of RNA-modulating therapeutics for rare genetic disorders. Their innovative treatments aim to address unmet medical needs in patients with Duchenne muscular dystrophy, myotonic dystrophy, and other rare neurodegenerative diseases. With a strong commitment to research and development, Prosensa is dedicated to improving the lives of individuals affected by these devastating conditions.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Nov 3 2026

4 Patents

#29 in Leiden

#1,340 in Netherlands

Leiden, NL
Leiden, Netherlands
Forward Citations = 95

9 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Prosensa Technologies B.v.. Retrieved from https://idiyas.com/company/prosensa-technologies-b-v

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…